130 related articles for article (PubMed ID: 12316798)
21. Clinics hard hit by drug price increases are focus of Senate hearing.
Wash Memo Alan Guttmacher Inst; 1991 Oct; (17):3-4. PubMed ID: 12284474
[TBL] [Abstract][Full Text] [Related]
22. Act (Chapter 13), 9 June 1988.
United States. Rhode Island
Annu Rev Popul Law; 1988; 15():20. PubMed ID: 12289393
[TBL] [Abstract][Full Text] [Related]
23. Highly effective copper IUD will hit U.S. market in 1988.
Contracept Technol Update; 1987 Dec; 8(12):149-52. PubMed ID: 12268926
[TBL] [Abstract][Full Text] [Related]
24. State efforts to expand Medicaid-funded family planning show promise.
Gold RB
Guttmacher Rep Public Policy; 1999 Apr; 2(2):8-11. PubMed ID: 12349124
[TBL] [Abstract][Full Text] [Related]
25. Norplant contraceptive maker accused of profiteering on drug.
Sun; 1993 Nov; ():13A. PubMed ID: 12287220
[TBL] [Abstract][Full Text] [Related]
26. Public funding for U.S. contraceptive services down since 1980 -- $95 million a year goes to sterilization.
Sukop S
AVSC News; 1992 Mar; 30(1):2-3. PubMed ID: 12285114
[TBL] [Abstract][Full Text] [Related]
27. Depo-Provera: costs eat up clinic contraceptive budgets.
Contracept Technol Update; 1999 Jan; 20(1):1-3. PubMed ID: 12349019
[TBL] [Abstract][Full Text] [Related]
28. States continue to expand eligibility for family planning services under Medicaid.
Gold RB
State Reprod Health Monit; 1996 Sep; 7(3):3-5. PubMed ID: 12347484
[TBL] [Abstract][Full Text] [Related]
29. Norplant Foundation increases eligibility with non-physician insertion.
Family Plan World; 1992; ():20. PubMed ID: 12290950
[TBL] [Abstract][Full Text] [Related]
30. Veto -- or threat thereof -- prevails over majority as 102nd Congress adjourns.
Wash Memo Alan Guttmacher Inst; 1992 Oct; (15):2-4. PubMed ID: 12317790
[TBL] [Abstract][Full Text] [Related]
31. A source of innovation.
Gillespie DG
Integration; 1992 Dec; (34):2-7. PubMed ID: 12317827
[TBL] [Abstract][Full Text] [Related]
32. Latest Medicaid waivers break new ground for family planning.
Gold RB
State Reprod Health Monit; 1997 Mar; 8(1):8-9. PubMed ID: 12347839
[TBL] [Abstract][Full Text] [Related]
33. Introducing new contraceptives.
Segal SJ; Coutinho E
Draper Fund Rep; 1986 Dec; (15):27-32. PubMed ID: 12341234
[TBL] [Abstract][Full Text] [Related]
34. Financing family planning services: is categorical legislation still needed?
Mcfarlane DR; Meier KJ
Am J Gynecol Health; 1991; 5(5-6):130-7. PubMed ID: 12344741
[TBL] [Abstract][Full Text] [Related]
35. Attitudes toward family planning.
Gille H
Draper Fund Rep; 1984 Jun; (13):3-5. PubMed ID: 12339637
[TBL] [Abstract][Full Text] [Related]
36. Future uncertain as Congressional drive to block Title X gag rule fails.
Wash Memo Alan Guttmacher Inst; 1991 Nov; (18):1-2, 4. PubMed ID: 12317314
[TBL] [Abstract][Full Text] [Related]
37. AGI report focuses on unanswered Norplant questions.
Family Plan World; 1993; 3(4):29. PubMed ID: 12288087
[TBL] [Abstract][Full Text] [Related]
38. Free Norplant to troubled teens.
Family Plan World; 1991; ():7. PubMed ID: 12346942
[TBL] [Abstract][Full Text] [Related]
39. Should oral contraceptives be sold over-the-counter?
Stone SC
Am J Gynecol Health; 1993; 7(2):27-32. PubMed ID: 12319537
[TBL] [Abstract][Full Text] [Related]
40. FDA gives final approval to Depo amid concerns over safety, cost and coercion.
Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):2-3. PubMed ID: 12344620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
